East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Brivaracetam Oral Solution, 10 mg/mL. Aurobindo Pharma’s Brivaracetam Oral Solution, are an AB-rated generic equivalent to the reference listed drug (RLD), Briviact® Oral Solution, manufactured by UBC, Inc. Brivaracetam Oral Solution are […] The post Aurobindo Receives FDA Approval for Brivaracetam Oral Solution, 10 mg/mL appeared first on Aurobindo Pharma USA .